Target intelligence / Profile preview

Plasmepsin I (None)

Target
None
Molecular classification
Enzyme, Aspartic protease, Peptidase A1/Pepsin-like
01

Overview

Plasmepsin I (PMI) is an aspartic protease enzyme found in the digestive vacuole of the malaria parasite *Plasmodium falciparum*. It plays a critical role in the initial steps of hemoglobin degradation during the parasite's asexual blood stage, which is essential for providing amino acids necessary for parasite growth and survival. Inhibition disrupts nutrient acquisition; however, due to redundancy among food vacuole plasmepsins and falcipains, inhibiting only one enzyme often does not suffice—multiple enzymes must be targeted simultaneously for effective antimalarial action. Selective inhibitors have been developed that preferentially bind PMI over human homologs like cathepsin D, offering potential therapeutic avenues while minimizing host toxicity.

Other names
Aspartic hemoglobinase IPFAPG
02

Mechanism of action

Inhibition of aspartic protease activity, disruption of hemoglobin degradation

03

Biological functions

Hemoglobin degradationProtein catabolismAmino acid supplyNutrient acquisition
04

Disease associations

InfectionMalaria
05

Safety considerations

Potential for off-target effects on human aspartic proteases (e.g., cathepsin D)Redundancy with other plasmepsins and falcipains necessitates multi-target approaches
06

Interacting drugs

KNI-10006

Beyond the preview

Go deeper on Plasmepsin I (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmepsin I (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call